Ceryvyn Therapeutics Limited share price logo

Ceryvyn Therapeutics Limited

PNK: CYVNY

$0.02

Live

as on

Ceryvyn Therapeutics Limited Stock Performance

as on October 21, 2026 at 4:41 am IST

  • Day's Low

    Day's High

    $0.02
    $0.02
    downward going graph

    16.67%

    Downside

    -16.67%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Ceryvyn Therapeutics Limited share price movements today

Previous Close
$0.02
Open
$0.02
Volume
17.7K
Market Cap
$4.1M
Day's Low - High
$0.02 - $0.02

Ceryvyn Therapeutics Limited Historical Returns

1 Month Return
+ 4.35 %
3 Month Return
-29.41 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Ceryvyn Therapeutics Limited Stock Fundamentals & Key Indicators

Check Ceryvyn Therapeutics Limited market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.1M

EPS (TTM)

-4.16

Dividend Yield

0.00%

PE Ratio (TTM)

-1.16

Industry PE ratio

0.00

PEG Ratio

0.07

Return On Equity TTM

520.65%

Ceryvyn Therapeutics Limited stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Ceryvyn Therapeutics Limited with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Ceryvyn Therapeutics Limited image
Ceryvyn Therapeutics Limited
NA$4.1MNA-1.16100.00%0.00%

Ceryvyn Therapeutics Limited Quarterly Profit & Loss

All numbers in Millions USD

Dec 2019
Jun 2020
Dec 2020
Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-11
-13
-26
-27
-53
-82
-117
-105
-143
-287
EBITDA
-11
-13
-26
-27
-53
-82
-115
-106
-138
-147
Interest Expense
-
-
-
-
-
-
5
14
16
30
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-12
-38
-29
-55
-84
-118
-102
-155
-192
Income Tax Expense
-3
4
-3
-3
-3
-4
-3
-5
-7
-6
Net Income
-7
-8
-34
-26
-51
-79
-115
-96
-147
-185
Net Profit Margin
25.31%
345.98%
100.00%
321.62%
100.00%
-170.97%
-54.12%
-53.50%
15.88%
-149.37%

Ceryvyn Therapeutics Limited Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Total Revenue
-
-
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
Operating Income
-9
-29
-36
-24
-53
-133
-223
-191
EBITDA
-9
-29
-36
-24
-50
-99
-223
-200
Interest Expense
-
-
-
-
-
-
13
30
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-9
-28
-35
-24
-67
-136
-220
-229
Income Tax Expense
-3
-12
14
8
-6
-8
-8
-9
Net Income
-6
-16
-20
-16
-60
-127
-211
-220
Net Profit Margin
0.00%
0.00%
-143.51%
-254.54%
-521.85%
-85.91%
-55.42%
17.42%

Ceryvyn Therapeutics Limited Quarterly Cash Flow

All numbers in Millions USD

Dec 2019
Jun 2020
Dec 2020
Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Net Income
-7
-8
-34
-26
-51
-79
-115
-96
-147
-185
Operating Cash Flow
3
-12
-24
-36
-39
-61
-103
-75
-106
-137
Investing Cash Flow
0
-
0
-
-
-
0
0
-
-
Financing Cash Flow
49
-1
164
-
0
-
249
-1
212
157
Change in Cash
53
-13
140
-202
-81
-63
87
-75
96
-230

Ceryvyn Therapeutics Limited Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Net Income
-6
-16
-20
-16
-60
-127
-211
-220
Operating Cash Flow
-6
-19
-24
-8
-61
-98
-179
-161
Investing Cash Flow
0
0
0
0
0
0
0
0
Financing Cash Flow
43
0
12
48
156
0
248
243
Change in Cash
37
-19
-10
40
95
-92
69
83

Global Institutional Holdings in Ceryvyn Therapeutics Limited

Check out the Institutions with significant holdings in Ceryvyn Therapeutics Limited.

Funds
Holdings
Felix Baker
1.22%

About Ceryvyn Therapeutics Limited

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the treatment of wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
OrganisationCeryvyn Therapeutics Limited
Headquarters650 Chapel Street, South Yarra, VIC, 3141, AU
IndustryBiotechnology
CEOJeremy Max Levin Ba Zoology, Dphil, Mb Bchir,

Key Management of Ceryvyn Therapeutics Limited

Name

Title

Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.

Executive Chair & CEO

Mr. Hamish George

CFO & Joint Company Secretary

Dr. Stuart Mudge

Chief Operating Officer

Dr. Michael Gerometta Ph.D.

Chief Technology Officer

Ms. Rebbecca Wilcox

Senior VP of Preclinical and Translational Science

Ms. Stephanie Vipond

Joint Company Secretary

FAQs

What is Ceryvyn Therapeutics Limited share price today?

Ceryvyn Therapeutics Limited share price today is $0.02 as on . Ceryvyn Therapeutics Limited share today touched a day high of $0.02 and a low of $0.02.

What is the 52 week high and 52 week low for Ceryvyn Therapeutics Limited share?

Ceryvyn Therapeutics Limited share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Ceryvyn Therapeutics Limited stock price today i.e. is trending at $0.02,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Ceryvyn Therapeutics Limited's market capitalisation today?

Ceryvyn Therapeutics Limited market capitalisation is $0.00T as on .

How to invest in Ceryvyn Therapeutics Limited Stock (CYVNY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ceryvyn Therapeutics Limited on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Ceryvyn Therapeutics Limited Stock (CYVNY) from India?

Indian investors can start investing in Ceryvyn Therapeutics Limited (CYVNY) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Ceryvyn Therapeutics Limited stock (as per the Rupee-Dollar exchange rate as on ). Based on Ceryvyn Therapeutics Limited share’s latest price of $0.02 as on October 20, 2026 at 11:11 pm IST, you will get 416.6667 shares of Ceryvyn Therapeutics Limited. Learn more about fractional shares .